StockData
argenx SE logo

argenx SE (ARGX) stock

ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 5/30
$947.52−3.43 (-0.36%)

Close on Nov 17, 2026Market cap –P/E 48.4Yield –

argenx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for argenx

argenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More argenx figures

See a number that looks wrong?